Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03889275
Title A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Research Site Phoenix Arizona 85054 United States Details
Research Site La Jolla California 92093 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Buffalo New York 14263 United States Details
Research Site New York New York 10065 United States Details
Research Site Chapel Hill North Carolina 27599 United States Details
Research Site Pittsburgh Pennsylvania 15232 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Leeds LS9 7TF United Kingdom Details
Research Site London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field